TP53 mutation and microsatellite instability status for the prediction of survival in adjuvant-treated colon cancer patients [3]

Journal of Clinical Oncology

Volumn 23, Issue 35, 2005, Pages 9031-9032

  Watanabe, Toshiaki ^a   Kanazawa, Takamitsu ^a   Kazama, Yoshihiro ^a   Tanaka, Junichiro ^a   Tanaka, Toshiaki ^a   Ishihara, Soichiro ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TUMOR MARKER; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; MICROSATELLITE DNA;

CANCER STAGING; CANCER SURVIVAL; COLON CANCER; DISEASE FREE SURVIVAL; GENE MUTATION; HUMAN; LETTER; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROGNOSIS; ADJUVANT CHEMOTHERAPY; COLON TUMOR; GENETICS; GENOMIC INSTABILITY; NOTE; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; FLUOROURACIL; GENES, P53; GENES, RAS; GENOMIC INSTABILITY; HUMANS; MICROSATELLITE REPEATS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 32044448575     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.0394     Document Type: Letter

References (8)

1. Westra JL, Schaapveld M, Hollema H, et al: Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage iii colon cancer patients. J Clin Oncol 23:5635-5643, 2005
2. Watanabe T, Wu TT, Catalano PJ, et al: Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344:1196-1206, 2001
3. Elsaleh H, Powell B, McCaul K, et al: P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 7:1343-1349, 2001
4. Halling KC, French AJ, McDonnell SK, et al: Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 91:1295-1303, 1999
5. Hemminki A, Mecklin JP, Jarvinen H, et al: Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 119:921-928, 2000
6. Elsaleh H, Joseph D, Grieu F, et al: Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355:1745-1750, 2000
7. Wu Y, Berends MJ, Mensink RG, et al: Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 65:1291-1298, 1999
8. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998